Publications by authors named "Claudia Gabaglia"

Seasonal influenza and the threat of global pandemics present a continuing threat to public health. However, conventional inactivated influenza vaccines (IAVs) provide little cross-protective immunity and suboptimal efficacy, even against well-matched strains. Furthermore, the protection against matched strains has been shown to be of a short duration in both mouse models and humans.

View Article and Find Full Text PDF

Introduction: The increasing burden of non-communicable diseases and limited public financing are major challenges facing health care systems in Latin America. Although COVID-19 severely impacted the Brazilian health care system, it is crucial to further characterize the degree of disruption caused to public health efforts, in order to address and manage long term effects of this pandemic. We therefore quantified the demand for preventive and treatment services from the Brazilian Unified Health System (Sistema Único de Saúde/SUS) in 2020 to evaluate potential repercussions of COVID-19 in this setting.

View Article and Find Full Text PDF

We describe a case of prolonged COVID-19 caused by the SARS-CoV-2 Gamma variant in a fully vaccinated healthcare worker, 387 days after an infection caused by lineage B.1.1.

View Article and Find Full Text PDF
Article Synopsis
  • Zika virus (ZIKV) is linked to serious birth defects, making it tough to diagnose infections during pregnancy; this study focused on tracking neutralizing antibodies in infants born to mothers who had confirmed ZIKV infections.
  • A total of 98 neonates were tested for ZIKV neutralizing antibodies (nAb) while also checking for evidence of vertical transmission and any clinical abnormalities over two years.
  • The results showed that many infants had evidence of vertical transmission but did not produce ZIKV nAb, challenging its usefulness for diagnosing congenital infections and raising questions about their susceptibility to future infections.
View Article and Find Full Text PDF

The autoimmune disease multiple sclerosis (MS) is driven by T cells that are reactive to self-antigens of the brain and spinal cord. Many drugs have been developed to treat MS, but we believe that immune-specific targeting of pathogenic T cells may be a better approach for treatment. This type of therapy identifies specific components of the self-reactive T-cell repertoire that would undergo similar natural selection criteria as those found in driver genes in cancer genesis.

View Article and Find Full Text PDF

We report Zika virus (ZIKV) vertical transmission in 130 infants born to PCR+ mothers at the time of the Rio de Janeiro epidemic of 2015-2016. Serum and urine collected from birth through the first year of life were tested by quantitative reverse transcriptase polymerase chain reaction (PCR) and/or IgM Zika MAC-ELISA. Four hundred and seven specimens are evaluated; 161 sera tested by PCR and IgM assays, 85 urines by PCR.

View Article and Find Full Text PDF

We report neurodevelopmental outcomes in 216 infants followed since the time of PCR-confirmed maternal Zika virus (ZIKV) infection in pregnancy during the Rio de Janeiro epidemic of 2015-2016 (refs. ). Neurodevelopment was assessed by Bayley Scales of Infant and Toddler Development, third edition (Bayley-III; cognitive, language and motor domains) in 146 children and through neurodevelopment questionnaires/neurological examinations in 70 remaining children.

View Article and Find Full Text PDF
Article Synopsis
  • Influenza A and B viruses lead to seasonal outbreaks with significant health impacts, prompting the need for effective vaccines, particularly since current quadrivalent vaccines have only about 42% efficacy against influenza B.
  • Researchers developed BM2-deficient, single-replication (BM2SR) influenza B vaccine viruses that safely induce strong immune responses to both Yamagata and Victoria lineages without causing disease in mice.
  • The BM2SR vaccine viruses demonstrated the ability to provide protective immunity against various strains of influenza B, showing potential as a platform for future trivalent vaccine development.
View Article and Find Full Text PDF
Article Synopsis
  • Congenital Zika virus (ZIKV) syndrome affects infants whose mothers were infected during pregnancy; this study looked at factors like maternal virus load and prior dengue immunity to understand its impact.
  • Researchers used a clinical severity tool to analyze symptoms in 131 pregnant women with ZIKV, finding a range of disease severity from mild to severe, with nearly half experiencing adverse outcomes.
  • The study concluded that there were no significant links between the severity of maternal illness, ZIKV viral load, or previous dengue antibodies with poor pregnancy or infant outcomes.
View Article and Find Full Text PDF
Zika virus and diagnostics.

Curr Opin Pediatr

February 2017

Purpose Of Review: The purpose of this review is to present what is known about the Zika virus (ZIKV) at the time of writing this review. The viral structure and its phylogeny, as well as the limitations of current available techniques used for diagnosis, are discussed.

Recent Findings: Crystallography and cryo-electron microscopy of the whole ZIKV, or a few of its proteins, are confirming its overall antigenic relatedness to other flaviviruses.

View Article and Find Full Text PDF

Background: Non Obese Diabetic mice lacking B cells (NOD.Igμ(null) mice) do not develop diabetes despite their susceptible background. Upon reconstitution of B cells using a chimera approach, animals start developing diabetes at 20 weeks of age.

View Article and Find Full Text PDF

Objective: STR/ORT mice provide a well-known model for murine idiopathic OA, with histological joint lesions resembling those of human OA. This model was used to investigate protective effects of the dipeptide aspartyl-phenylalanine-1-methyl ester (Asp-Phe-OMe or aspartame) via the oral route vs a regular diet.

Methods: STR/ORT mice were housed individually and fed diets with or without Asp-Phe-OMe (4 mg/kg), after weaning at the age of 3 weeks, until 15 months of age (average of 20 animals per group).

View Article and Find Full Text PDF

Background: Tumor immune responses are first generated and metastases often begin in tumor sentinel lymph nodes (TSLN). Therefore, it is important to promote tumor immunity within this microenvironment. Mifepristone (RU486) treatment can interfere with cortisol signaling that can lead to suppression of tumor immunity.

View Article and Find Full Text PDF

Following Leishmania major infection, the early LACK (Leishmania homolog of receptors for activated C kinase)-induced IL-4 response appears to determine disease susceptibility in BALB/c mice. Therefore, we sought to manipulate the pathogenic T cell responses to the immunodominant epitope with the use of altered peptide ligands (APLs). Conservative and non-conservative substitutions for each amino acid of the LACK 161-175 peptide determinant were tested for their stimulatory capacity in four different LACK-reactive T cell systems.

View Article and Find Full Text PDF

Immunization with soluble leishmanial antigen (SLA) in IFA plus Ad5IL-12 vector induced protection confined to the immunized footpad in BALB/c mice. However, animals that controlled a primary infection with a Leishmania major challenge in the same immunized footpad, became resistant to subsequent contralateral rechallenges due to expansion of IFN-gamma secreting cells. This systemic immunity could be disrupted either by macrophage depletion during immunization or by lymphadenectomy after challenge.

View Article and Find Full Text PDF

To study the T cell responses induced by native and modified Ag, we have followed in vivo TCR selection and cytokine profile of T cells, as well as the isotype of induced Abs, in response to the model Ag hen egg-white lysozyme (HEL) and its reduced and carboxymethylated form (RCM-HEL). RCM-HEL induces in vivo a T cell response focused on the same immunodominant determinant characterizing the response to native HEL, but further skewed to the Th1 pathway. No difference between HEL and RCM-HEL could be observed in the efficiency of processing, nor in the type of APCs involved.

View Article and Find Full Text PDF

Nasal installation or oral feeding of antigens can alter the subsequent immune response in animals and humans. Most mucosal treatments with antigens tend to down-regulate disease, inducing full tolerance or immune deviation; however, priming has also been reported. We evaluated the course of experimental autoimmune encephalomyelitis (EAE) in (SJL x B10.

View Article and Find Full Text PDF

Background: Nasal instillation is an effective method for inducing antigen-specific immune tolerance. However, it is not clear how a tolerization scheme established in one mouse strain will perform when used in a mouse of a different haplotype.

Objectives: To compare the antigen-specific recall responses in four mouse strains--BALB/c, C57BL/6, NOD, and B10.

View Article and Find Full Text PDF